Lataa...

A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells

BACKGROUND: The survival rate of patients with head and neck squamous cell carcinoma (HNSCC) stands at approximately 50% and this has not improved in decades. This study developed a novel sirtuin-3 (SIRT3) inhibitor (LC-0296) and examined its role in altering HNSCC tumorigenesis. MATERIALS AND METHO...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Anticancer Res
Päätekijät: ALHAZZAZI, TURKI Y., KAMARAJAN, PACHIYAPPAN, XU, YANLI, AI, TENG, CHEN, LIQIANG, VERDIN, ERIC, KAPILA, YVONNE L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5417072/
https://ncbi.nlm.nih.gov/pubmed/26722027
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!